Notice for vosoritide (BioMarin Pharmaceuticals Australia Pty Ltd)
Active ingredients
vosoritide
Date of review outcome
Lapse date
Type
Orphan drug
Dosage form(s)
Powder for injection and water for injection
Indication
For the treatment of achondroplasia (ACH)
Therapeutic area
Inherited bone disorder